<div class="entities" style="line-height: 2.5; direction: ltr">Admission Date:  [**2183-1-9**]              Discharge Date:   [**2183-1-15**]<br><br>Date of Birth:  [**2129-8-15**]             Sex:   F<br><br>Service: OBSTETRICS/GYNECOLOGY<br><br>Allergies:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Codeine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Doxycycline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dilaudid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>Attending:[**Doctor First Name 5911**]<br>Chief Complaint:<br>Ms. [**Known lastname 111230**] presented for scheduled laparoscopic bilateral<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    salpingo
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    oophorectomies
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 due to bilateral ovarian cysts with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    solid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 components.<br><br>Major Surgical or Invasive Procedure:<br>1. Laparoscopic bilateral salpingo-oophorectomies,<br>pelvic peritoneal washings with emergent conversion to<br>laparotomy for repair of trocar injury to left common iliac<br>artery and vein.<br>2. Primary repair of left common iliac artery.<br>3. Primary repair of left common iliac vein.<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    transfusion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
.<br><br><br>History of Present Illness:<br>Ms. [**Known lastname 111230**] is a 53-year-old G4, P4-0-0-4 perimenopausal<br>Caucasian female with bigeminy arrhythmia, depression, GERD, and<br>is S/P C/S x4 plus 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LTL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Ms. [**First Name (Titles) 111231**] [**Last Name (Titles) 1834**] a pelvic<br>ultrasound [**12/2179**] for complaints of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    abnormal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bleeding
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  It<br>revealed a 7.7 cm right posterior cul-de-sac cyst separate from<br>the right ovary and a 3.5 cm simple left ovarian cyst.  The<br>uterus measured 10.9 cm but was otherwise unremarkable with<br>endometrial stripe of 8 mm.  She had a followup pelvic<br>ultrasound ([**2180-2-2**]) that revealed resolution of the 7.7 cm<br>posterior 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cul
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
-
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    de
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
-sac cyst with a normal right adnexa.  She had<br>two left ovarian cysts sizing 2-2.5 cm.  Endometrial stripe<br>measured 1.1 cm with a questionable 6-mm 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    endometrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    polyp
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>.<br>In regards to her endometrial lesion and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    abnormal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bleeding
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, she<br>[**Year (4 digits) 1834**] an office endometrial biopsy ([**2180-1-18**]).  It<br>revealed scant inactive endometrium with no evidence of<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    endometrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hyperplasia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 or 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    malignancy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  A diagnostic office<br>hysteroscopy ([**2180-4-19**]) revealed a normal endometrial cavity<br>with no evidence of any endometrial polyps or submucosal<br>fibroids.  There were no active issues regarding the endometrial<br>findings and the patient maintained expectant management.  In<br>regards to her abnormal bleeding, given the benign endometrial<br>biopsy and normal hematocrit, the patient opted to maintain<br>expectant management.<br>.<br>In regards to her pelvic and left 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ovarian
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cysts
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, it appeared<br>that the patient had remained asymptomatic and this was an<br>incidental finding.  The large 7.7 cm right posterior cul-de-sac<br>cyst had resolved spontaneously and the left adnexal cyst<br>appeared to be oscillating in size and simple in nature.<br>Therefore, the patient opted to maintain expectant management<br>with intermittent surveillance given her asymptomatic state.<br>.<br>She recently had a pelvic ultrasound at [**Location (un) 620**] under Dr.[**Name (NI) 14510**]<br>(PCP) instructions.  PUS ([**2182-11-12**]) at [**Hospital1 **] [**Location (un) 620**] reveals a<br>uterus measuring 11 x 4.2 x 6 cm.  Endometrial stripe measured 7<br>mm.  No endometrial polyp was appreciated.  The right ovary<br>measured 3 cm in its greatest dimension with a large 8.9 x 4 cm<br>cyst containing some debris.  There was additionally a smaller<br>1.3 cm nodule within it.  A third cystic area with flow was also<br>noted along the edge of this large 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cystic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lesion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  On the left,<br>the left ovary measured 5 cm in its greatest dimension and<br>contained a 2.2 cm simple 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cyst
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  There was an additional 1.1-cm<br>solid nodule &amp; a small amount of free 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 in the cul-de-sac.<br>.<br>She denied any symptoms related to these PUS findings such as<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pelvic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  On review of her menstrual pattern, she does<br>report a pattern of 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    oligomenorrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 consistent with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    perimenopause
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  She did skip her menses in [**4-/2182**], [**5-/2182**], and<br>[**6-/2182**] and has then resumed monthly menses in [**Month (only) 205**] with each<br>episode lasting roughly five to 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    eight
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    days
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
.  The amount of<br>bleeding is lighter than her prior moderate to heavy flow noted<br>two years ago. The patient continues to remain asymptomatic.<br>Given the size of the lesions and the solid components, I<br>advised surgical management even though she remains<br>asymptomatic. After careful consideration, the patient would<br>like to proceed with surgical evaluation.  A plan for a<br>laparoscopic bilateral salpingo-oophorectomies with possible<br>conversion to laparotomy was discussed.  Pelvic peritoneal<br>washings will be obtained.  We also discussed the need for a<br>staging procedure should surgical findings reveal a malignant<br>condition.  The patient was consented for a laparoscopic<br>bilateral salpingo-oophorectomies, pelvic peritoneal washings,<br>possible laparotomy, and possible staging procedure.  She<br>understands that a staging procedure will be performed by one of<br>our gynecologic-oncologist here at [**Hospital1 18**] if indicated (greatly<br>appreciated).  The nature of the surgery, potential surgical<br>risks, likely hospital and postoperative course were discussed<br>with the patient in detail today.  Informed consent was<br>obtained.<br><br><br>Past Medical History:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    OB
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 history:  G4, P4-0-0-4<br>- C-sections (x4), [**2154**], [**2156**], [**2157**], and [**2160**].<br><br>GYN History:  Menarche age 12.  see above for menstrual hx<br>- denies pelvic pain, dyspareunia, pain w/ full bladder or BM.<br>- denies h/o abnormal Pap smears, last Pap ([**2182-11-4**]) neg 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SIL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>- last mammogram ([**2181-12-18**]) reportedly neg per pt. next<br>mammogram<br>is scheduled for 1/[**2183**].<br>-  she is sexually active, prefers opposite sex and reports one<br>sexual partner throughout life. s/p LTL in [**2163**].<br>- STD History:  Negative.<br><br>Medical Problems:<br>1.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bigeminy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    arrhythmia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>2.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Depression
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>3.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GERD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>4.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Abnormal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bleeding
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>5.  
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Mitral
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    valve
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    prolapse
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br>Past Surgical History:<br>1. C-section x4 ([**2154**], [**2156**], [**2157**], and [**2160**])<br>2. [**2163**], Laparoscopic tubal ligation, D&amp;C, for permanent<br>sterilization and abnormal bleeding evaluation.<br><br><br>Social History:<br>Denies history of smoking or recreational 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    drug
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 use.  ~2<br>Etohic drinks per week. not currently employed and married,<br>living with her husband. denies history of abuse.<br><br><br>Family History:<br>- father with hypertension and heart disease<br>- denies fam h/o breast, ovarian, uterine, cervical, vaginal,<br>colon, or any other cancers.  denies fam h/o diabetes,<br>hypercholesterolemia, or any other family medical conditions.<br><br><br>Physical Exam:<br>GENERAL: Pleasant Caucasian female in no acute distress.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    VITAL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SIGNS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: BP 100/60, wt 122 pds, ht 5 ft 0 in.<br>HEENT: normocephalic/atraumatic, anicteric sclera<br>Neck: supple, full range of motion, no thyromegaly or nodules<br>Lymphatic: no palpable neck lymphadenopathy<br>Back: no CVA tenderness<br>Lungs: clear to auscultation bilaterally, good inspiratory<br>effort<br>CV: regular rate and rhythm, no murmurs/rubs/gallops<br>Abdomen is soft, nontender, nondistended, positive bowel sounds.<br>No rebound or guarding.  Well-healed low transverse C-section<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    scar
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  Well-healed laparoscopic punctures.  Unremarkable exam.<br>Extremities: no clubbing/cyanosis/edema<br>On bimanual exam, the patient has a small, anteverted, nontender<br>uterus.  It is difficult to palpate the right adnexal cyst ?<br>fullness, but no firm parameters appreciated.  No left adnexal<br>masses.  No CMT, benign exam.<br><br><br>Pertinent Results:<br>[**2183-1-9**] 04:54PM BLOOD WBC-11.8*# RBC-2.33*# Hgb-7.0*#<br>Hct-20.5*# MCV-88 MCH-29.9 MCHC-34.0 RDW-13.5 Plt Ct-215<br>[**2183-1-9**] 05:40PM BLOOD WBC-10.5 RBC-2.68* Hgb-7.9* Hct-23.4*<br>MCV-87 MCH-29.7 MCHC-34.0 RDW-13.5 Plt Ct-123*<br>[**2183-1-9**] 07:33PM BLOOD WBC-8.2 RBC-2.64* Hgb-7.9* Hct-22.4*<br>MCV-85 MCH-30.0 MCHC-35.3* RDW-13.6 Plt Ct-104*<br>[**2183-1-10**] 12:43AM BLOOD WBC-9.7 RBC-3.18* Hgb-9.5* Hct-27.0*<br>MCV-85 MCH-29.8 MCHC-35.0 RDW-13.9 Plt Ct-88*<br>[**2183-1-10**] 06:27AM BLOOD WBC-10.1 RBC-3.45* Hgb-10.4* Hct-29.1*<br>MCV-84 MCH-30.1 MCHC-35.7* RDW-13.9 Plt Ct-101*<br>[**2183-1-11**] 07:45AM BLOOD WBC-8.8 RBC-3.18* Hgb-9.6* Hct-27.3*<br>MCV-86 MCH-30.2 MCHC-35.2* RDW-14.1 Plt Ct-125*<br>[**2183-1-12**] 07:55AM BLOOD WBC-5.8 RBC-3.01* Hgb-9.1* Hct-25.7*<br>MCV-86 MCH-30.1 MCHC-35.2* RDW-13.6 Plt Ct-119*<br>[**2183-1-12**] 12:50PM BLOOD WBC-5.4 RBC-3.00* Hgb-9.2* Hct-25.7*<br>MCV-86 MCH-30.5 MCHC-35.7* RDW-13.8 Plt Ct-131*<br>[**2183-1-13**] 08:10AM BLOOD WBC-4.8 RBC-3.02* Hgb-8.9* Hct-25.8*<br>MCV-86 MCH-29.6 MCHC-34.7 RDW-13.8 Plt Ct-173<br>[**2183-1-14**] 08:14AM BLOOD WBC-4.9 RBC-3.28* Hgb-9.7* Hct-28.2*<br>MCV-86 MCH-29.7 MCHC-34.5 RDW-14.2 Plt Ct-208<br>[**2183-1-9**] 04:49PM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fibrino
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
113*<br>[**2183-1-9**] 07:33PM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fibrino
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-157<br>[**2183-1-10**] 12:43AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fibrino
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-179<br>[**2183-1-10**] 06:27AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fibrino
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-285#<br>[**2183-1-12**] 07:55AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Fibrino
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
822*#<br>[**2183-1-9**] 07:33PM BLOOD Glucose-181* UreaN-12 Creat-0.8 Na-142<br>K-3.8 Cl-111* HCO3-23 AnGap-12<br>[**2183-1-10**] 12:43AM BLOOD Glucose-134* UreaN-11 Creat-0.6 Na-140<br>K-3.9 Cl-110* HCO3-25 AnGap-9<br>[**2183-1-10**] 06:27AM BLOOD Glucose-136* UreaN-11 Creat-0.6 Na-139<br>K-3.7 Cl-109* HCO3-26 AnGap-8<br>[**2183-1-11**] 07:45AM BLOOD Glucose-100 UreaN-7 Creat-0.5 Na-143<br>K-3.3 Cl-109* HCO3-28 AnGap-9<br>[**2183-1-12**] 07:55AM BLOOD Glucose-115* UreaN-9 Creat-0.5 Na-138<br>K-3.3 Cl-107 HCO3-25 AnGap-9<br>[**2183-1-13**] 08:10AM BLOOD Glucose-115* UreaN-11 Creat-0.6 Na-139<br>K-3.4 Cl-108 HCO3-27 AnGap-7*<br>[**2183-1-14**] 08:14AM BLOOD Glucose-110* UreaN-10 Creat-0.6 Na-138<br>K-3.3 Cl-106 HCO3-27 AnGap-8<br>[**2183-1-9**] 07:33PM BLOOD ALT-30 AST-41* AlkPhos-47 TotBili-0.4<br>[**2183-1-9**] 04:47PM BLOOD Type-MIX pO2-58* pCO2-55* pH-7.12*<br>calTCO2-19* Base XS--12 Intubat-INTUBATED<br>[**2183-1-9**] 05:56PM BLOOD Type-ART Rates-12/0 Tidal V-586 PEEP-5 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    O2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>Flow-4 pO2-460* pCO2-37 pH-7.31* calTCO2-20* Base XS--6<br>Intubat-INTUBATED Vent-CONTROLLED<br>[**2183-1-9**] 08:11PM BLOOD Type-ART Temp-35.5 Rates-/12 Tidal V-500<br>PEEP-5 FiO2-60 pO2-307* pCO2-38 pH-7.41 calTCO2-25 Base XS-0<br>-
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ASSIST
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CON
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 Intubat-INTUBATED<br>[**2183-1-10**] 01:18AM BLOOD Type-[**Last Name (un) **] pH-7.30* Comment-GREEN TOP<br><br>Brief Hospital Course:<br>Ms [**Known lastname 111230**] [**Last Name (Titles) 1834**] laparoscopic bilateral<br>salpingoophorectomies and pelvic washings that was complicated<br>by a trocar injury to the left common iliac artery and vein<br>injury.  She had an emergent conversion to a laparotomy with a<br>primary vessel repair (with assistance from Gynecologic<br>Oncology, General Surgery, and [**Last Name (Titles) **] Surgery-- please see<br>operative reports for details). Ms. [**Known lastname 111230**] was transferred<br>after the procedure to the ICU intubated, in stable conditon.<br>Patient was extubated in AM POD#1 and called out of the ICU.<br>Her course is described below by system:<br>.<br>RESPIRATOY: Ms. [**Known lastname 111230**] was extubated on post-operative day #1<br>and had no respiratory complications during her admission.<br>.<br>HEME: Ms. [**Known lastname 111230**] [**Last Name (Titles) 1801**] was noted to have a consumptive<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coagulopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. She recieved a total of 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10u
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRBC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    7u
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FFP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1000cc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cellsaver
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1u
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    plts
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 in terms of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    products
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
. Her<br>post-operative HCT was stable.  The INR and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fibrinogen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were<br>followed and noted to normalize by discharge. She remained<br>hemodynamically stable and never required 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pressors
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 in her<br>post-operative course.<br>.<br>[**Last Name (Titles) **]: [**Last Name (Titles) **] surgery followed her as a consultative<br>service and advised q4 hour pulse checks, bedside ABIs, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DVT
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>prophylaxis (
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hep
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 ppx transitioned to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    81mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
),<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    compression
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stockings
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 as outpatient, activity restrictions as an<br>outpatient and follow-up with Dr. [**Last Name (STitle) **].<br>.<br>ID: Ms. [**Known lastname 111230**] was treated with a broad spectrum 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>regimen including 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cipro
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Flagyl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 from [**1-9**] until<br>[**1-12**]. She remained afebrile on and off 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>.<br>FEN/GI: Patient complained of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  She was treated with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Zofran
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Protonix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Reglan
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tums
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bicitra
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 likely<br>secondary to medications and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GERD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. She had bowel movements,<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    flatus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and no abdominal distension, making the diagnosis of<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ileus
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 unlikely. Her diet was advanced as tolerated. Nutrition<br>was consulted to ensure appropriate calorie intake. Ms.<br>[**Known lastname 111232**] weight was noted to be elevated and her exam revealed<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    from
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    retention
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. She responded well to diuresis with<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lasix
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>.<br>NEURO: Ms. [**Known lastname 111232**] 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 was well-controlled with a 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    morphine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>PCA which was transtioned to 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    po
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vicodin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on [**2183-1-13**] POD#4.  She<br>demonstrated full neurologic function and was alert and oriented<br>throughout her recovery.<br>.<br>OTHER: Social work consult was offered to aid in family coping<br>and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    deconditioning
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, but patient declined. Patient with strong<br>family support.  Physical therapy was consulted.<br>.<br>She recovered smoothly and was transferred from the ICU to the<br>VICU on POD#1, then to a regular floor on post-operative day #5<br>and discharged home on postoperative day #6 in good condition:<br>ambulating and urinating without difficulty, tolerating a<br>regular diet, and with adequate 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    control
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 using 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>medication. She had follow-up with the [**Year (4 digits) 1106**] and gynecology<br>services.<br><br>Medications on Admission:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ERYTHROMYCIN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
  (Prescribed by Other Provider) - 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 -<br>
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    one
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    s
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    by
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mouth
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LORAZEPAM
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 [
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ATIVAN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
] -  (Prescribed by Other Provider) - Dosage<br>uncertain<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SERTRALINE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 -  (Prescribed by Other Provider) - 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 -<br>
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    one
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    s
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    by
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mouth
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br><br><br>Discharge Medications:<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hydrocodone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablets
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q4H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: maximum 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tylenol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
) is 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4000mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
, each 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Vicodin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 contains 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tylenol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
).<br>Disp:*50 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pantoprazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Delayed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 (E.C.) Sig: One<br>(
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
) 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Delayed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 (E.C.) 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q24H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    24
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>Disp:*30 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>
, 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Delayed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Release
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    E
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    C
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
(s)* Refills:*2*<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    81
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>Disp:*30 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*2*<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ondansetron
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rapid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dissolve
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rapid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dissolve
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q8H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    8
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Disp:*40 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ,
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rapid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dissolve
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>

<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    s
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
)* Refills:*0*<br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lorazepam
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    QID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (4 times a<br>day) as needed for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    anxiety
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Disp:*60 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    prochlorperazine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    maleate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Disp:*60 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ibuprofen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    600
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>hours) as needed for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>Disp:*60 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*0*<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    500
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (every<br>6 hours).<br>Disp:*120 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
(s)* Refills:*2*<br><br><br>Discharge Disposition:<br>Home<br><br>Discharge Diagnosis:<br>complex 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ovarian
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cysts
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>laceration 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    to
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    common
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    iliac
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vein
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    and
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 artery<br><br><br>Discharge Condition:<br>Mental Status: Clear and coherent.<br>Level of Consciousness: Alert and interactive.<br>Activity Status: Ambulatory - Independent.<br><br><br>Discharge Instructions:<br>Call your doctor for:<br>* fever &gt; 100.4<br>* 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    abdominal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>* difficulty urinating<br>* 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vaginal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bleeding
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 requiring &gt;1 pad/hr<br>* abnormal vaginal discharge<br>* redness or drainage from incision<br>* 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    nausea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vomiting
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 where you are unable to keep down fluids/food<br>or your medication<br><br>General instructions:<br>* Take your medications as prescribed.<br>* Do not drive while taking 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    narcotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>* No strenuous activity, nothing in the vagina (no tampons, no<br>douching, no sex), no heavy lifting of objects &gt;10lbs for 6<br>weeks. * You may eat a regular diet.<br><br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Incision
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 care:<br>* You may shower and allow 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    soapy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    water
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 to run over incision; no<br>scrubbing of incision.  No bath tubs for 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 weeks.<br>* If you have staples, they will be removed at your follow-up<br>visit.<br><br><br>Followup Instructions:<br>Please call Dr.[**Name (NI) 93885**] office for a follow-up appointment for<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    staple
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    removal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 this Friday.<br><br>Please call Dr.[**Name (NI) 111233**] office for a follow-up in 2 weeks.<br><br>Provider: [**Name6 (MD) **] [**Name11 (NameIs) **], MD Phone:[**Telephone/Fax (1) 8246**] Date/Time:[**2183-2-14**]<br>8:00<br>Provider:  [**Name10 (NameIs) **] [**Name11 (NameIs) 3628**] (NHB) Phone:[**Telephone/Fax (1) 1237**]<br>Date/Time:[**2183-2-14**] 9:15<br>Provider: [**Name10 (NameIs) 14633**],EQUIPMENT [**Name10 (NameIs) **] [**Name10 (NameIs) 3628**] (NHB) Phone:[**Telephone/Fax (1) 1237**]<br>Date/Time:[**2183-2-14**] 10:15<br><br><br>                             [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 5913**]<br><br></div>